TP53 and breast cancer: We identified two TP53 mutations (patient 2: TP53 p.R248L and patient 14: TP53 p.R283P) that were present in purified breast cancer cells, suggesting these mutations originated from the epithelial, malignant clone (Supplementary Table 4).